PEGylation-Dependent Metabolic Rewiring of Macrophages with Silk Fibroin Nanoparticles
Open Access
- 12 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (16) , 14515-14525
Abstract
Silk fibroin nanoparticles are emerging as promising nanomedicines, but their full therapeutic potential is yet to be realized. These nanoparticles can be readily PEGylated to improve colloidal stability and to tune degradation and drug release profiles; however, the relationship between silk fibroin nanoparticle PEGylation and macrophage activation still requires elucidation. Here, we used in vitro assays and nuclear magnetic resonance based metabolomics to examine the inflammatory phenotype and metabolic profiles of macrophages following their exposure to unmodified or PEGylated silk fibroin nanoparticles. The macrophages internalized both types of nanoparticles, but they showed different phenotypic and metabolic responses to each nanoparticle type. Unmodified silk fibroin nanoparticles induced the upregulation of several processes, including production of proinflammatory mediators (e.g., cytokines), release of nitric oxide, and promotion of antioxidant activity. These responses were accompanied by changes in the macrophage metabolomic profiles that were consistent with a proinflammatory state and that indicated an increase in glycolysis and reprogramming of the tricarboxylic acid cycle and the creatine kinase/phosphocreatine pathway. By contrast, PEGylated silk fibroin nanoparticles induced milder changes to both inflammatory and metabolic profiles, suggesting that immunomodulation of macrophages with silk fibroin nanoparticles is PEGylation-dependent. Overall, PEGylation of silk fibroin nanoparticles reduced the inflammatory and metabolic responses initiated by macrophages, and this observation could be used to guide the therapeutic applications of these nanoparticles.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/CTM/50011/2019)
- Nanyang Technological University
- Engineering and Physical Sciences Research Council (EP/M508159/1)
- Ministério da Ciência, Tecnologia e Ensino Superior
- University of Strathclyde (1715)
This publication has 57 references indexed in Scilit:
- Cancer nanomedicine: progress, challenges and opportunitiesNature Reviews Cancer, 2016
- Ligand-targeted theranostic nanomedicines against cancerJournal of Controlled Release, 2016
- Principles of nanoparticle design for overcoming biological barriers to drug deliveryNature Biotechnology, 2015
- Principles in the design of ligand-targeted cancer therapeutics and imaging agentsNature Reviews Drug Discovery, 2015
- Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfallsExpert Opinion on Drug Delivery, 2014
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNature Nanotechnology, 2013
- Understanding biophysicochemical interactions at the nano–bio interfaceNature Materials, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Immunological properties of engineered nanomaterialsNature Nanotechnology, 2007
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003